Picture of Wakamoto Pharmaceutical logo

4512 — Wakamoto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Table: Wakamoto Pharm -9-MTH parent results

Feb 3 (Reuters)-  
             Wakamoto Pharmaceutical Co Ltd  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             8.34                8.57             11.20     
                 (-2.7 pct)          (+5.1 pct)       (+0.1 pct)   
  Operating        70 mln              221 mln          60 mln     
                 (-68.0 pct)         (-33.1 pct)      (-27.9 pct)  
  Recurring        113 mln             280 mln          40 mln     
                 (-59.7 pct)         (-29.3 pct)      (-68.0 pct)  
  Net              73 mln              168 mln           2 mln     
                 (-56.3 pct)         (-33.8 pct)      (-90.2 pct)  
  EPS             2.12 yen            4.85 yen         0.06 yen    
  Ann Div                             3.00 yen                     
  -Q2 div            NIL                 NIL                       
  -Q4 div                             3.00 yen                     
   
  NOTE - Wakamoto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Wakamoto Pharmaceutical

See all news